1673-534X
2007 Issue 3
The relation of peroxisome proliferators activated receptor γ、thiazolidinediones and nonalcoholic fatty liver disease
WANG xiao-min;CHEN Dong-feng;AI Zheng-lin
WANG xiao-min;CHEN Dong-feng;AI Zheng-lin
..............page:219-221
Precancerous lesions of hepatocellular carcinoma
CHEN Qiong-rong;HU Rui-de
CHEN Qiong-rong;HU Rui-de
..............page:222-224
Study progress of the gastrointestinal nerve-ICC-smooth muscle network
LI yi;QI Qing-hui
LI yi;QI Qing-hui
..............page:225-227
Progress of Skp2 in the tumor of human digestive system
SONG Jun;XU Shao-yong
SONG Jun;XU Shao-yong
..............page:228-230
The role of kupffer cells in the pathogeny of alcoholic liver disease of rats
zhou jun ying ; yao shu kun ; zhao cai yan ; zhen zhen
zhou jun ying ; yao shu kun ; zhao cai yan ; zhen zhen
..............page:231-232,224
Peroxisome proliferator-activated receptor gamma and hepatoma
WU Xu-dong;CHEN Wei-chang
WU Xu-dong;CHEN Wei-chang
..............page:216-218
Fulminant Wilson disease
LUO Hong-yu;YANG Xu
LUO Hong-yu;YANG Xu
..............page:213-215
..............page:211-212,215
Smad7 and liver fibrosis
RUAN Yi-hua;LIU Hai-lin
RUAN Yi-hua;LIU Hai-lin
..............page:208-210
Research progress of relationship between endotoxin and fatty liver disease
LI Sheng;WU Wan-chun
LI Sheng;WU Wan-chun
..............page:205-207
Endothelin and haemodynamics in liver disease
YU Xiao-hu;ZHU Jin-shui
YU Xiao-hu;ZHU Jin-shui
..............page:203-204,207
The research progress in hyperlipidemic sever acute pancreatitis
GUO Li-fen;SHEN Xiao-ling;WANG Jian-guo
GUO Li-fen;SHEN Xiao-ling;WANG Jian-guo
..............page:200-202
Advances experimental studies on melatonin intervention acute pancreatitis
WU Ai-rong;XU Chun-fang
WU Ai-rong;XU Chun-fang
..............page:197-199
Protection of melatonin against gastric ulcer and its mechanism
CHEN Jian-yong;SHEN Xue-wen;ZHANG Ji-xiang
CHEN Jian-yong;SHEN Xue-wen;ZHANG Ji-xiang
..............page:194-196
Oxygen radicals in helicobacter pylori associated gastric disease
ZENG Ya-min;SI Jian-min
ZENG Ya-min;SI Jian-min
..............page:191-193
Advances of cDNA microarray technology in gastric disease
WANG Xia;FANG Jing-yuan
WANG Xia;FANG Jing-yuan
..............page:188-190
Clinical presentation and diagnosis of primary small intestinal tumor
ZHANG Zi-yan;ZHONG Jie
ZHANG Zi-yan;ZHONG Jie
..............page:186-187,196
The role of STAT proteins in the pathogenesis Of inflammatory bowel disease
NIU Hong-yao;ZHANG Xiao-lan
NIU Hong-yao;ZHANG Xiao-lan
..............page:182-185
Therapy effect of growth factors on inflammatory bowel disease
HE Ying;OUYANG Qin
HE Ying;OUYANG Qin
..............page:164-166
Hematopoietic stem cell transplantation: a new therapy for inflammatory bowel disease
XUE Ru-yi;ZHANG Shun-cai
XUE Ru-yi;ZHANG Shun-cai
..............page:162-163,166
..............page:159-161
Current opinion on the correlation with functional constipation and psychology and autonomic nerve
WANG Hui-fen;ZHAO Hong-chuan
WANG Hui-fen;ZHAO Hong-chuan
..............page:180-181,190
Enteric nervous system and slow transit constipation
CHEN Lan;LIU Shi
CHEN Lan;LIU Shi
..............page:178-179,185
Interleukin-12 and crohn disease
ZHENG Zhong;CHEN Wei-xiong
ZHENG Zhong;CHEN Wei-xiong
..............page:175-177
Current research situation of the relationship between irritable bowel syndrome and inflammation
CHEN Hao;KE Mei-yun
CHEN Hao;KE Mei-yun
..............page:172-174,177
Recent advances on infliximab in the treatment of moderate-to-severe ulcerative colitis
HE Xiang-yi;CHEN Wei-xiong
HE Xiang-yi;CHEN Wei-xiong
..............page:169-171
Visceral hypersensitivity in irritable bowel syndrome
YOU Yuan-ming;LIU Jin-song
YOU Yuan-ming;LIU Jin-song
..............page:167-168,171